Evidence map›Paper›PMID 20089728›Full record

ArticleThe American journal of clinical nutrition2010

Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos.

Zeina Makhoul, Alan R Kristal, Roman Gulati, Bret Luick, Andrea Bersamin, Bert Boyer, Gerald V Mohatt

Abstract read
In one paragraph

Article in The American journal of clinical nutrition, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase 1A.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Article
  14. Review
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zeina MakhoulDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. zmakhoul@fhcrc.org
Alan R Kristal
Roman Gulati
Bret Luick
Andrea Bersamin
Bert Boyer
Gerald V Mohatt
University of Alaska Fairbanks · USFred Hutch Cancer Center · US

Funding

YUP'IK PERCEPTIONS OF BODY WEIGHT AND DIABETESP20RR016430 · NCRR · UNIVERSITY OF ALASKA FAIRBANKS · PI BERSAMIN, ANDREA · 2001 to 2011
$23.4M
NCRR NIH HHS P20 RR16430
6 · The paper itself

Abstract

backgroundFew studies have examined the associations of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with biomarkers of chronic disease risk in populations with high intakes.

objectiveWe examined the associations of red blood cell (RBC) EPA and DHA, as percentages of total fatty acids, with biomarkers of chronic disease risk across a wide range of EPA and DHA intakes.

designIn a cross-sectional study of 357 Yup'ik Eskimos, generalized additive models were used to plot covariate-adjusted associations of EPA and DHA with chronic disease biomarkers. Linear regression models were used to test for the statistical significance of these associations.

resultsMeans (5th-95th percentiles) for RBC EPA and DHA were 2.8% (0.5-5.9%) and 6.8% (3.3-9.0%), respectively. Associations of EPA and DHA were inverse and linear for triglycerides (beta +/- SE = -0.10 +/- 0.01 and -0.05 +/- 0.01, respectively) and positive and linear for HDL cholesterol (beta +/- SE = 2.0 +/- 0.5 and 0.9 +/- 0.6, respectively) and apolipoprotein A-I (beta +/- SE = 2.6 +/- 0.8 and 1.7 +/- 0.8, respectively). Positive linear associations of DHA with LDL and total cholesterol (beta +/- SE = 7.5 +/- 1.4 and 6.80 +/- 1.57, respectively) were observed; for EPA, these associations were nonlinear and restricted to concentrations approximately <5% of total fatty acids. Associations of EPA and DHA with C-reactive protein were inverse and nonlinear: for EPA, the association appeared stronger at concentrations approximately >3% of total fatty acids; for DHA, it was observed only at concentrations approximately >7% of total fatty acids.

conclusionIncreasing EPA and DHA intakes to amounts well above those consumed by the general US population may have strong beneficial effects on chronic disease risk.

Indexed as

InuitAdolescentAdultApolipoprotein A-IBiomarkersCholesterolChronic DiseaseC-Reactive ProteinCross-Sectional StudiesDietary FatsDocosahexaenoic AcidsDose-Response Relationship, DrugEicosapentaenoic AcidErythrocytesFemaleHumansApolipoprotein A-IBiomarkersCholesterolC-Reactive ProteinDietary FatsDocosahexaenoic AcidsEicosapentaenoic AcidLipidsTriglycerides

Identifiers

PMID20089728
PMCPMC2824158
OpenAlexW2006519435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.